Chemotherapy resistance in K562 CML cells has also been associated with CXCR4 upregulation in addition to PI3K/AKT pathway activation and NF-κB nuclear translocation, highlighting an important signalling axis [24]. Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.